XENCOR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.94 USD | -0.62% |
|
+13.99% | -1.37% |
| 16/04 | BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating | MT |
| 09/04 | Xencor Names Bart Cornelissen as Chief Financial Officer | MT |
Chart calendar Xencor, Inc.
f4f805092b1deb9fdc504b7d249109.Hb2wQgCspX5_q-KmeLq0TqlGWnHhh6SiZbvZq8WK_h0.VfyBDljYyTMdmYzsKuXdIJ0lL0PYtOvwXPLp2vTFtVR408QPNebfBCju1g~fa4a20f04465a85da66336eb7cb90ea1
Upcoming events on Xencor, Inc.
Past events on Xencor, Inc.
| 14/03/2024 08:45 pm | Barclays Global Healthcare Conference |
| 13/03/2024 06:50 pm | Leerink Partners Global Biopharma Conference |
| 13/03/2024 | Jefferies Biotech on the Bay Summit |
| 06/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 28/02/2024 03:00 am | Q4 2023 Earnings Call |
| 28/02/2024 02:31 am | Q4 2023 Earnings Release |
| 11/01/2024 05:15 am | JPMorgan Healthcare Conference |
| 28/11/2023 06:30 pm | Piper Sandler Healthcare Conference |
| 08/11/2023 03:00 am | Q3 2023 Earnings Call |
| 08/11/2023 02:31 am | Q3 2023 Earnings Release |
| 01/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number 1193 |
| 01/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number 1060 |
| 01/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number 764 |
| 04/08/2023 02:00 am | Q2 2023 Earnings Call |
| 04/08/2023 01:31 am | Q2 2023 Earnings Release |
| 15/06/2023 02:00 am | Annual General Meeting |
| 31/05/2023 | EULAR European Rheumatology Congress |
| 09/05/2023 02:00 am | Q1 2023 Earnings Call |
| 09/05/2023 01:31 am | Q1 2023 Earnings Release |
| 17/04/2023 11:00 pm | American Association for Cancer Research Meeting - Abstract No 2983 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 157 168 -6.47% | 123 112 9.09% | 275 195 41.41% | 165 164 0.61% | 168 194 -13.23% | 93,3 |
|
EBITDA Million USD | Released Forecast Spread | 18,1 18,0 0.68% | -71,0 -102 30.28% | 51,3 7,00 632.26% | -73,7 -79,6 7.41% | -127 19,8 -741.98% | -181 |
|
EBIT Million USD | Released Forecast Spread | 13,8 16,8 -17.81% | -76,8 -89,6 14.3% | 43,8 -38,6 213.44% | -82,5 -92,0 10.39% | -139 -87,8 -57.82% | -215 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 27,2 31,1 -12.7% | -69,3 -85,8 19.19% | 82,6 21,5 283.87% | -54,5 -92,2 40.86% | -120 -103 -17.43% | -194 |
|
Net income Million USD | Released Forecast Spread | 26,9 30,7 -12.39% | -69,3 -85,9 19.25% | 82,6 19,5 323.96% | -55,2 -95,0 41.89% | -126 -103 -22.49% | -204 |
|
EPS USD | Released Forecast Spread | 0,46 0,50 -7.3% | -1,21 -1,50 19.47% | 1,37 0,32 326.91% | -0,93 -1,51 38.28% | -2,08 -1,73 -19.92% | -3,34 |
| Announcement Date | 24/02/20 | 24/02/21 | 23/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 154 76,3 101.88% | 85,5 26,2 226.7% | 30,2 34,0 -11.28% | 27,3 21,1 29.66% | 21,6 19,2 12.32% | 19,0 27,2 -30.23% | 45,5 26,3 73.24% | 59,2 30,0 96.99% | 44,7 74,7 -40.18% | 25,0 | 24,5 | 24,6 | 25,6 | 34,1 |
|
EBITDA Million USD | Released Forecast Spread | 93,8 53,0 76.91% | 28,6 -40,5 170.8% | -25,8 -38,9 33.79% | -36,1 -26,6 -35.91% | -40,4 -38,3 -5.57% | -57,1 -42,4 -34.69% | -23,1 -49,5 53.31% | -15,1 -26,2 42.22% | -30,4 112 -127.16% | -28,3 | -28,3 | -28,7 | -29,3 | -32,8 |
|
EBIT Million USD | Released Forecast Spread | 91,7 13,6 574.15% | 26,5 -38,8 168.26% | -28,0 -29,3 4.57% | -38,3 -40,4 4.97% | -42,6 -47,6 10.51% | -59,4 -42,1 -41.14% | -26,0 -49,2 47.18% | -18,3 -44,1 58.58% | -33,6 16,4 -305.47% | -49,6 | -52,2 | -53,6 | -52,5 | -46,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 73,1 20,0 264.51% | 23,6 -39,7 159.45% | -34,0 -28,8 -17.88% | -31,7 -43,0 26.42% | -12,5 -45,7 72.76% | -60,8 -40,7 -49.19% | -22,0 -47,1 53.35% | -24,3 -44,2 45.14% | -13,5 4,90 -374.46% | -44,7 | -47,1 | -51,4 | -50,8 | -44,8 |
|
Net income Million USD | Released Forecast Spread | 73,1 17,6 315.71% | 23,6 -39,3 160.07% | -34,0 -31,2 -9.01% | -32,8 -44,6 26.48% | -12,0 -48,3 75.05% | -60,8 -40,5 -50.14% | -22,0 -47,3 53.63% | -24,3 -43,0 43.5% | -19,1 3,50 -646.03% | -47,6 | -49,4 | -52,9 | -52,0 | -44,8 |
|
EPS USD | Released Forecast Spread | 1,21 0,10 1074.76% | 0,39 -0,64 160.94% | -0,57 -0,47 -20.25% | -0,55 -0,68 18.98% | -0,20 -0,80 75.15% | -1,02 -0,66 -55.47% | -0,37 -0,79 53% | -0,40 -0,71 43.74% | -0,31 0,01 -3041.18% | -0,78 | -0,80 | -0,86 | -0,85 | -0,79 |
| Announcement Date | 23/02/22 | 05/05/22 | 03/08/22 | 07/11/22 | 23/02/23 | 08/05/23 | 03/08/23 | 07/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Xencor, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XNCR Stock
- Calendar Xencor, Inc.
